BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Das D, Hong J. Prostaglandin E2 Receptor 4 (EP4): A Promising Therapeutic Target for the Treatment of Cancer and Inflammatory Diseases. CCB 2021;15:50-68. [DOI: 10.2174/2212796814999201222101310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Litak J, Czyżewski W, Szymoniuk M, Sakwa L, Pasierb B, Litak J, Hoffman Z, Kamieniak P, Roliński J. Biological and Clinical Aspects of Metastatic Spinal Tumors. Cancers 2022;14:4599. [DOI: 10.3390/cancers14194599] [Reference Citation Analysis]
2 Wang W, He J, Yang J, Zhang C, Cheng Z, Zhang Y, Zhang Q, Wang P, Tang S, Wang X, Liu M, Lu W, Zhang HK. Scaffold Hopping Strategy to Identify Prostanoid EP4 Receptor Antagonists for Cancer Immunotherapy. J Med Chem 2022. [PMID: 35640059 DOI: 10.1021/acs.jmedchem.2c00448] [Reference Citation Analysis]